Oncolytics Biotech
(NASDAQ) ONCY
Oncolytics Biotech Financials at a Glance
Market Cap
$93.52M
Revenue (TTM)
CA$0.00
Net Income (TTM)
-CA$35.52M
EPS (TTM)
-$0.25
P/E Ratio
-3.70
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$0.95
Volume
2,728
Open
$0.96
Price
$0.95
Volume
2,728
Open
$0.96
Previous Close
$0.93
Daily Range
$0.95 - $0.98
52-Week Range
$0.56 - $1.51
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$0.95
Volume
2,728
Open
$0.96
Previous Close
$0.93
Daily Range
$0.95 - $0.98
52-Week Range
$0.56 - $1.51
Estimated Earnings Date
Aug 6, 2026
ONCY News
A New Cancer-Killing Virus
This Week in Biotech
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oncolytics Biotech
Industry
Biotechnology
Sector
Health CareEmployees
29
CEO
Jared Kelly
Website
www.oncolyticsbiotech.comHeadquarters
Calgary, AB T2R 0C5, CA
ONCY Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-11839%
Return on Capital
-13%
Return on Assets
-4%
Earnings Yield
-27.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$93.52M
Shares Outstanding
100.36M
Volume
2.73K
Avg. Volume
1.27M
Financials (TTM)
Gross Profit
-CA$70.00K
Operating Income
-CA$39.41M
EBITDA
-CA$39.41M
Operating Cash Flow
-CA$27.60M
Capital Expenditure
-CA$8.23K
Free Cash Flow
-CA$27.60M
Cash & ST Invst.
CA$7.14M
Total Debt
CA$772.51K
Oncolytics Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$0.00
N/A
Gross Profit
-CA$22.31K
-17.4%
Gross Margin
0.00%
N/A
Market Cap
$93.52M
N/A
Market Cap/Employee
$3.34M
N/A
Employees
28
N/A
Net Income
-CA$12.89M
-92.8%
EBITDA
-CA$12.92M
-87.2%
Quarterly Fundamentals
Total Cash
CA$5.49M
-64.1%
Total Debt
CA$508.00K
-49.2%
Accounts Receivable
CA$961.00K
+979.8%
Inventory
CA$0.00
N/A
Long Term Debt
CA$342.00K
-51.8%
Short Term Debt
CA$166.00K
-42.8%
Return on Assets
-4.35%
N/A
Return on Invested Capital
-12.96%
N/A
Free Cash Flow
-CA$10.17M
-56.5%
Operating Cash Flow
-CA$10.17M
-56.5%